Refine by
Therapeutics Gout Discovery Services
9 services found
by:Immunai based inNew York, NEW YORK (USA)
Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions' Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of ...
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Veracyte offers customized biomarker testing and analytical services to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs. We do this by leveraging our novel insights into the molecular underpinnings of disease and our extensive experience in drug development. Our immuno-oncology offerings focus on the implications of the ...
Manufactured by:MuseChem based inPaoli, PENNSYLVANIA (USA)
Bioconjugation is a strategy to form a stable covalent bond between two molecules, at least one of which is a biomolecule. As a cross-linking technique, bioconjugation has been widely used to create functional biomolecules for specific biomarkers imaging, cellular events tracking, protein biodistribution determination, enzyme function revealing and drug ...
Manufactured by:Akebia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Tenacity: At Akebia, we are inspired to think boldly and move bold thinking into action. We leverage our scientific expertise and this innovative thinking to develop clinical advances in areas that are important to people living with kidney disease. We thrive as collaborators because we believe that we can go further together. We work with partners across the globe to pioneer and grow new areas ...
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
Hybridoma technology features the effective usage of innate functions of both immune and cancer cells to generate monoclonal antibodies (mAbs). The resulting hybridoma cell lines are produced to combat specific antigens of interest. Such technology has forged remarkable new approaches toward therapeutic mAb discovery, as well as disease diagnosis and ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
CardioPRIME® is the AnaBios approach for measuring human cardiomyocyte functionality and sets the industry standard for cardiac-based biomedical research. By leveraging the robust excitation-contraction coupling of mature primary human cardiomyocytes and direct measurements of sarcomeric length, CardioPRIME offers unprecedented insight into cardiomyocyte functionality and provides ...
by:Oncodesign based inDijon, FRANCE
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, Oncodesign has been a player known for its experience and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...